FDA Inspection 1099645 — PlasmaLab International, Inc.

PlasmaLab International, Inc. — FEI 3023431

The FDA completed an inspection of PlasmaLab International, Inc. on August 15, 2019 in Everett, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 15, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Everett, WA (United States)

Citations

IDCFRDescription
1220321 CFR 606.170(a)Adverse Reaction- Reports of Investigations